AzTrials
AzTrials

Child Abuse SexualReDirectionNCT06133569

ReDirection - Self Help Program for Individuals with Sexual Interest in Children

A study testing ReDirection in people with Child Abuse Sexual and Pedophilia, run by Karolinska Institutet at 6 sites in 6 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse. Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors? Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Child Abuse Sexual, Pedophilia
What is being tested?
ReDirection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
6 sitesin 6 countries
Study dates
27 Sep 2023to 10 Oct 2024
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
  • concern about sexual interest regarding children*,
  • CSAM use past six month
  • Low to medium risk for committing child sexual abuse according to the SChiMRA scale

Who cannot join

  • Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.

Trial locations and contacts

6 sites in 6 countries. Contact the study team or a site near you to ask about taking part.

Christoffer Rahm, MD, PhD contact

+46793393723

christoffer.rahm@ki.se

Maria Breide contact

+46735563825

maria.breide@ki.se

6 sites in 6 countries

Czechia1 site, 1 recruiting
  • National Institute of Mental Health

    Klecany

    Katerina Klapilova, Ass Professor

    Recruiting

Other trials in Czechia

Finland1 site, 1 recruiting
  • Protect Children NGO

    Helsinki

    Nina Vaarhanen-Valkonen

    Recruiting

Other trials in Finland

Germany1 site, 1 recruiting
  • [University Medical Center Hamburg-Eppendorf

    Hamburg

    Peer Briken, Professor

    Recruiting

Other trials in Germany

Slovakia1 site, 1 recruiting
  • Bratislava Police Academy

    Bratislava

    Josef Metenko, Professor

    Recruiting

Other trials in Slovakia

Spain1 site, 1 recruiting
  • Universitat Jaume I

    Castelló

    Rafael Ballester, Professor

    Recruiting

Other trials in Spain

Sweden1 site, 1 recruiting
  • Centre for psychiatry research, Region Stockholm

    Stockholm, 11842

    Christoffer Rahm, MD PhD, +46793393723, christoffer.rahm@ki.se

    Christoffer Rahm, MD PhD

    Recruiting

Other trials in Sweden

About this study

Official title: A Multicenter, Waitlist Controlled, Randomized Clinical Trial of the Effectiveness of a Self Help Program Based on Cognitive Behavioral Therapy for Individuals with Sexual Interest in Children.

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse.

Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Read the detailed description

The present research project aims to contribute to the further development of accessible, evidence-based and safe care for people with concerns about their sexual interest regarding children, and that are using child sexual abuse material (CSAM), so that these people can access treatment according to their needs and level of risk, with the objective of reducing the risk for child sexual abuse and improving the health of the group.

More concretely, we aim to evaluate a revised version of an already available cognitive-behavioral self-help program, ReDirection, with the aim of testing whether this intervention can reduce sexual interest regarding children and CSAM use, in a group of people assessed as being at low or medium risk of committing sexual abuse of children. The intervention will be available in seven languages and will be tested in six countries.

Primary research question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Secondary research questions: Is ReDirection effective in reducing research subjects' overall risk of committing sexual acts involving children? Does ReDirection reduce specific dynamic risk factors for committing CSA?

ReDirection is based on cognitive behavioral therapy and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors. At the end of the program, participants are offered an anonymous follow-up chat and if needed during the program, participants can contact a practitioner via chat.

Research subjects will be recruited through Darknet and Clearnet. Darknet refers to websites that are accessible via TOR or similar services. The interventions are provided by practitioners and researchers in the relevant countries.

ReDirection will be evaluated through an international multicenter study using randomized wait-list controlled design.

The research subjects will sign a written consent form on the Iterapi platform without disclosing personal data such as name or location. During the subsequent screening interview via chat or voice call on Iterapi, participation criteria are ensured, questions are answered, and the consent to participate is confirmed. The research subjects are thus admitted to the study.

After inclusion, participants answer the baseline survey which consists of validated self-assessment questionnaires with both multiple choice and free-text answers.

Weekly during, after the waitlist, and after the therapeutic intervention, research subjects answer questions to evaluate the effectiveness and safety of the interventions.

A Statistical Analysis Plan (SAP) based on pilot study is pre-registered at the OSF platform. The SAP describes sample size calculations, and planned analyses of outcome measures.

Being tested
ReDirection
Keywords
Child sexual abuse material, Cognitive behavioral therapy, Internet based self-help program, Individuals with sexual interest in children
Medical subject headings
Pedophilia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReDirectionBehavioural

    Self help program based on principles for cognitive behavioral therapy

Study groups in NCT06133569
Study groupRoleWhat they receive
ReDirectionExperimentalReDirection is a self help program based on cognitive behavioral therapy methodology and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors.
Receives: Behavioral: ReDirection
WaitlistNo interventionParticipants are on a waitlist which means they have no active intervention, only weekly measurements with the same questionnaires as in the active arm.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sexual interest involving children

    Measured by Sexual Symptom Assessment Scale (SASS)(0-48 points; higher scores indicate more interest).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  2. Child sexual abuse material usage

    Measured with Sexual Child Molestation Risk Assessment (SChiMRA+), part B, item 1 (self-reported time spent last week in hours watching CSAM) including 3 follow up questions (about time/day, severity, and of youngest child).

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  3. Other behaviors related to sexual interest in children.

    Time spent last week (hours), as self reported on the SChiMRA+ scale part B, item 4.

    Measured: Pre-intervention, during the intervention, and immediately after the intervention.

  4. Depressive symtoms

    Scores on the PHQ-9 questionnaire (Patient Health Questionnaire; 0-27 points; higher scores indicate more severe depressive symptoms).

    Measured: Pre-intervention, and immediately after the intervention.

Secondary outcomes (2)
  1. Dynamic risk for committing child sexual abuse

    Scores on Acute-2007 (21 items; 0-42 points; higher scores indicate higher dynamic risk for committing child sexual abuse)

    Measured: Pre-intervention, during the intervention,and immediately after the intervention.

  2. Level of hypersexuality

    Scores on the HBI-19 questionnaire (Hypersexual Behavior Inventory; 19-95 points; higher scores indicate higher level of sexuality; more than 52 points indicate hypersexuality)

    Measured: Pre-intervention, and immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2023
  2. Study start27 Sep 2023
  3. Primary completion10 Oct 2024 (estimated)
  4. Study completion10 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Participants are allocated to either the ReDirection intervention or waitlist during the initial phase of the study and those who receive waitlist receive ReDirection during the second phase of the study.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06133569
Sponsor's protocol ID
2023-02321-01
Other IDs
101084355-BRIDGE-ISF-2021, 2023
Acronym
ReDirection
Status last verified
Oct 2024
First submitted
12 Oct 2023
Last updated
10 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing ReDirection in people with Child Abuse Sexual and Pedophilia, run by Karolinska Institutet at 6 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Czechia, Finland, Germany, Slovakia, Spain and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christoffer Rahm, MD, PhD (+46793393723, christoffer.rahm@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sexual interest involving children (time frame: Pre-intervention, during the intervention, and immediately after the intervention.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2024; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in